Will exercise advice be sufficient for treatment of young adults with pre-hypertension and hypertension? A systematic review and meta-analysis. by Williamson, Wilby et al.
                          Williamson, W., Foster, C., Reid, H., Kelly, P., Lewandowski, A. J.,
Boardman, H., ... Leeson, P. (2016). Will exercise advice be sufficient for
treatment of young adults with pre-hypertension and hypertension? A
systematic review and meta-analysis. Hypertension, 68(1), 78-87.
https://doi.org/10.1161/HYPERTENSIONAHA.116.07431
Publisher's PDF, also known as Version of record
License (if available):
CC BY-NC
Link to published version (if available):
10.1161/HYPERTENSIONAHA.116.07431
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via the American Heart
Association at https://doi.org/10.1161/HYPERTENSIONAHA.116.07431 . Please refer to any applicable terms of
use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
78
Population studies estimate 1 in 17 adults below the age of 40 years are hypertensive1 with higher prevalence in 
those with diabetes mellitus, obesity, familial predisposition, 
or prenatal and other early childhood factors.2–7 Hypertension 
in early life significantly increases the risk of stroke and car-
diovascular disease before the age of 50 years.8–11 However, 
rates of diagnosis are consistently lower in younger adults 
and, even when identified, control is frequently subopti-
mal.5,12–14 This may relate to an acceptance of higher blood 
pressures because of a perceived lower 5-year cardiovascular 
risk, particularly for those in the prehypertensive range. This 
is despite epidemiological evidence of cumulative vascular 
protection and lower disease burden in later life after change 
in blood pressure and lifestyle during early adulthood.9,15–17 
Together, these observations may explain why 1 in 5 strokes 
still occur in the below 55 years age group.18
To reduce burden of early stroke and cardiovascular 
disease, evidence-based guidance is required to improve 
hypertension prevention and management for young adult 
populations. Exploring heterogeneity in response pattern 
Abstract—Previous studies report benefits of exercise for blood pressure control in middle age and older adults, but longer-
term effectiveness in younger adults is not well established. We performed a systematic review and meta-analysis of 
published randomized control trials with meta-regression of potential effect modifiers. An information specialist 
completed a comprehensive search of available data sources, including studies published up to June 2015. Authors 
applied strict inclusion and exclusion criteria to screen 9524 titles. Eligible studies recruited younger adults with a 
cardiovascular risk factor (with at least 25% of cohort aged 18–40 years); the intervention had a defined physical activity 
strategy and reported blood pressure as primary or secondary outcome. Meta-analysis included 14 studies randomizing 
3614 participants, mean age 42.2±6.3 (SD) years. At 3 to 6 months, exercise was associated with a reduction in systolic 
blood pressure of −4.40 mm Hg (95% confidence interval, −5.78 to −3.01) and in diastolic blood pressure of −4.17 
mm Hg (95% confidence interval, −5.42 to −2.93). Intervention effect was not significantly influenced by baseline blood 
pressure, body weight, or subsequent weight loss. Observed intervention effect was lost after 12 months of follow-up 
with no reported benefit over control, mean difference in systolic blood pressure −1.02 mm Hg (95% confidence interval, 
−2.34 to 0.29), and in diastolic blood pressure −0.91 mm Hg (95% confidence interval, −1.85 to 0.02). Current exercise 
guidance provided to reduce blood pressure in younger adults is unlikely to benefit long-term cardiovascular risk. There 
is need for continued research to improve age-specific strategies and recommendations for hypertension prevention 
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to exercise and linking exercise response with hyperten-
sive and cardiovascular phenotypes identifiable within 
younger subgroups may be of value in future studies and 
offer opportunity to deliver more personalized and targeted 
intervention strategies. Current guidelines recommend spe-
cialist review of young adults with elevated blood pressure 
because the risk of hypertension may be underestimated in 
the below 40 years age group.19 In the absence of significant 
end organ disease or secondary causes of elevated blood 
pressure, young adults below 40 years of age are encour-
aged to implement lifestyle changes, in particular regular 
exercise, as the first line for hypertension management.20,21 
A limitation of this guidance is that it is based on data from 
physical activity trials in older populations with mean ages 
>50 years.22,23 There are many potential modifiers of inter-
vention effect which are not consistent across age groups, 
including baseline physical activity,24 barriers to participa-
tion,25 and physiological training adaptations.26 Therefore, 
we performed a new systematic review and meta-analysis to 
evaluate the quality of the evidence base and effectiveness 
of exercise intervention to reduce blood pressure in younger 
adult populations.
Methods
Protocol registration: PROSPERO (www.crd.york.ac.uk/PROSPERO/) 
registration number CRD42014009604.
Search Strategy and Selection Criteria
We completed a systematic review in accordance with established 
methods for Cochrane reviews of physical activity interventions 
(Online-only Data Supplement S1). We adhered to the Cochrane 
Handbook for Intervention Reviews and PRISMA statement (Data 
Supplement S2). An information specialist (N.R.) searched the fol-
lowing databases: Cochrane Central Register of Controlled Trials, 
MEDLINE & MEDLINE In Process, EMBASE, CINAHL, AMED, 
PsycINFO, SPORTdiscus, OpenGrey, Science Citation Index & 
Conference Proceedings Citation Index-Science, ACM Digital 
Library, and IEEE Xplore Digital Library. Cochrane highly sensitive 
search was used to identify randomized controlled trials. No language 
or date restrictions were applied. Bibliographies of review articles 
and selected articles were examined for relevant trials. Literature 
searches completed up to June 2015. Full description of data sources 
and search summary are available in the online-only Data Supplement 
(Data Supplement S1; Table S1).
Study Selection and Data Extraction
We included studies with mean population age between 18 and 40 
years or within 1 SD of this range to ensure at least 25% of the 
study population were <40 years of age. To be representative of 
young adults who may be provided advice to manage blood pres-
sure, included studies were required to recruit participants with 
≥1 cardiovascular risk factor, or family history of cardiometabolic 
risk. Risk factors included hypertension or prehypertension (sys-
tolic blood pressure ≥120 mm Hg or diastolic blood pressure ≥80 
mm Hg), overweight (mean body mass index >25 kg/m2) but not 
severely obese (body mass index ≥35 kg/m2), diabetes mellitus, 
metabolic syndrome, dyslipidaemia, smoking, and alcohol con-
sumption. The defined body mass index exclusion criteria were 
based on the understanding that severely obese populations have 
higher burden of comorbidities and potential functional barriers to 
exercise participation that makes them a unique target audience. 
Studies examined the effectiveness of interventions with defined 
exercise, physical activity or cardiovascular fitness components. 
The comparator was a control group exposed to placebo, no or 
minimal intervention. Blood pressure was reported as a primary 
or secondary outcome after a minimum follow-up of 3 months. 
Studies were required to have >80% complete follow-up data ana-
lyzing the results by intention-to-treat or, if not applying inten-
tion-to-treat, ensuring <20% study attrition. Additional details on 
inclusion criteria provided in the online-only Data Supplement 
(Data Supplement S1).
Titles and abstracts were screened independently by paired au-
thors (W.W., H.R., A.L., and P.K.). Two authors (W.W. and H.R.) 
independently reviewed full-text articles and extracted data. Study 
inclusion was agreed by consensus in discussion with other authors 
(C.F. and P.L.). Missing or ambiguous data were clarified with the 
corresponding author. We assessed risk of bias for studies that met 
inclusion criteria for meta-analysis using the Cochrane Risk of Bias 
Tool, which was expanded to include risk areas specific for physi-
cal activity and blood pressure interventions (Data Supplement S1). 
Quality of included studies were summarized using the Grading 
of Recommendations Assessment, Development and Evaluation 
(GRADE) approach.27
Statistical Analysis
Studies were analyzed using mean and SD of outcomes expressed in 
the original papers. Clinic blood pressures, measured at rest, were 
reported across all studies and used as the outcome measures. We 
expressed effect size using the mean difference between the postint-
ervention values of the randomized groups. If required, we imputed 
SDs from SEs and confidence intervals (CIs) using methods 
described in the Cochrane handbook.27 When studies investigated 
multiple interventions arms, intervention arms inclusive of exercise 
were included as individual intervention strata. Mean values were 
plotted with associated error bars using forest plots. Statistically 
significant results were identified as CIs excluding a null effect and 
P value of <0.05. Heterogeneity was assessed through examination 
of the forest plots and quantified using the I2 statistic. I2 statistics 
were graded according to Cochrane interpretation (>75% consid-
erable/large heterogeneity). Reporting bias was assessed by plot-
ting a funnel plot of intervention effect on blood pressure (Data 
Supplement S1).
We completed meta-analysis according to Cochrane methods,27 
using RevMan version 5.2 statistical software.28 A random-effects 
model was the default to incorporate heterogeneity between studies, 
the inverse variance method was used to calculate the overall effect 
and SE.29
Planned subgroup analysis of included studies was completed ac-
cording to the following covariants: (1) baseline blood pressure, (2) 
baseline weight, (3) delivery method, whether exercise was self-di-
rected or supervised, (4) estimated contact time between participants 
and intervention, (5) target intensity of exercise, and (6) change in 
weight after intervention (Data Supplement S1).
Meta-regression analysis was performed using the Wilson 
(2010) SPSS macro using IBM SPSS Statistics for Windows, 
version 22.0.30 Meta-regression was performed using a random-
effects model to examine whether study level covariates (potential 
effect modifiers) predict intervention effect on systolic and dia-
stolic blood pressure between studies at 3 to 6 months follow-up. 
A priori the following factors where agreed for inclusion in the 
meta-regression model: (1) mean arterial blood pressure combin-
ing systolic and diastolic blood pressure, (2) estimated contact 
time between participants and intervention, (3) target exercise 
intensity during intervention, and (4) effect of intervention on 
weight loss calculated as the standard mean difference between 
intervention and control post intervention to allow comparison 
between studies reporting change in weight and body mass index 
(FigureS3a and S3b).
Results
Results of Search
We screened 9524 titles and abstracts reviewing 786 full-text 
articles (Figure 1). We identified 14 randomized control tri-
als (RCTs) with 20 exercise intervention arms for inclusion, 
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published between 1985 and 2015 (Table 1; Table S2). The 
RCTs randomized 3614 participants with a recognized car-
diovascular risk factor, mean age 42.2 years (SD, 6.3). Over 
75% of participants were white and only 35% were female 
(Table 1). The studies recruited prehypertensive and stage 
1 hypertensive participants. The majority of stage 1 hyper-
tensives were not medicated at time of intervention, 1 study 
included participants that continued with antihypertensive 
prescription (n=15).
Excluded studies, with explanation of exclusion listed 
in the online-only Data Supplement (Table S3). The major 
reason for study exclusion was age of population outside 
inclusion criteria (n=323; Figure 1). One hundred fifty-
eight of these studies reported blood pressure as a pri-
mary outcome, of these, 73 studies excluded participants 
<35 years of age. None of the excluded cardiovascular 
studies performed subgroup analysis separating interven-
tion effects by age. Other common explanations for study 
exclusion included non-RCT design or lack of true exercise 
control arms (n=181), or study objectives focused on acute 
or short-term exercise response, primarily in healthy par-
ticipants (n=51).
Description of Included Studies
The majority of participants received a combined behav-
ioral intervention with a defined physical activity strategy 
(Table S2). Eighteen intervention exercise arms targeted 
increase in moderate to vigorous physical activity, 12 
intervention arms delivered structured, supervised aerobic 
exercise programs in gym and group environments with 
intensity defined by baseline exercise testing. Seven trial 
intervention arms promoted self-directed increase in physi-
cal activity supported by regular group and individual coun-
seling sessions. Behavioral counseling was delivered by 
multidisciplinary professional groups. Contact time with the 
intervention in the first 3 months ranged from 5 to 48 hours, 
average 25 hours. The average in the first 3 months for stud-
ies reporting 3- to 6-month outcome was 30 hours (Table 
S2). The minimum follow-up for inclusion in the present 
systematic review was 3 months, 10 studies report 3 to 6 
months of follow-up data (15 intervention arms, n=2716). 
Five studies complete follow-up at 3 months and 6 stud-
ies report follow-up after 12 months (8 intervention arms, 
n=3023, Table S2).
Figure 1. PRISMA flow diagram describing the screening and selection of studies for inclusion in meta-analysis.
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Risk of Bias and Quality Assessment
The funnel plot of intervention effect on systolic blood pres-
sure was symmetrical about the mean effect size line, sug-
gesting there was no particular study publication bias (Figure 
S1). Overall quality of the included RCTs using the GRADE 
approach suggests moderate quality data (Figure S2). In total, 
9 studies are downgraded secondary to study design and out-
come reporting being unclear or at risk of bias with limited 
reporting of participant allocation methods and lack of clari-
fication of blinding during outcome assessment. A significant 
limitation of the included studies was the lack of reference 
to published study protocols that adhere to the template for 
intervention description and replication.31 Only the Trials of 
Hypertension Prevention (TOHP) and ProActive UK stud-
ies consistently reference published study protocols (Data 
Supplement S3; Table S2).
Table 1. Baseline Description of Study Populations Participating in RCTs Included in Meta-Analysis
Study
Mean Age 
(SD) Age Range, Y Female, %
Weight, kg 
(SD) BMI, kg/m2
Intervention Group, BP 
mm Hg
Control Group, BP  
mm Hg
Systolic Diastolic Systolic Diastolic
Duncan, 1985 30.4 (.) 21–37 0 86.4 (14) … 146.3 (5.9) 94.3 (4) 145 (5.5) 93.3 (3.8)
Stamler, 1989 37 (3.5) 30–44 13 84.3 (11) … 122.2 (6.7) 82.4 (2.8) 122.9 (7) 82.6 (3)
Blumenthal, 1991 
Aerobic Exercise
45.2 (7.8) 29–59 38 82 (13) 27 141 (9) 96 (6) 142 (12) 96 (6)
Blumenthal, 1991 
Strength
45.2 (7.8) 29–59 42 81 (15) 27.2 143 (10) 95 (5) 142 (12) 96 (6)
Stevens 1993
TOPH Weight Loss 
and Exercise
42.8 (6.1) 30–54 32 89.7 (13) 29.5 124.3 (8.4) 83.7 (2.6) 124.6 (8.1) 84 (3)
Whelton 1997
TOHP Combined 
Lifestyle
43.6 (6.2) 30–54 31 93.6 (14.2) … 127.4 (6.5) 86 (1.9) 127.3 (6.4) 85.8 (1.9)
Whelton 1997
TOHP Weight Loss 
and Exercise
43.4 (6.1) 30–54 37 93.4 (14.1) … 127.6 (6.1) 86 (1.9) 127.3 (6.4) 85.8 (1.9)
Blumenthal 2000 
Aerobic exercise
46.6 (8.8) >29 54 95.4 (14.5) 32.8 138.1 (15.4) 93.6 (7.3) 143.8 (6.9) 94.4 (3.4)
Blumenthal 2000 
Aerobic exercise 
and Weight
48.5 (8.9) >29 62 93.3 (17.7) 32.1 142.7 (10.4) 93.2 (5.2) 143.8 (6.9) 94.4 (3.4)
Tsai 2002 41 (8.6) 20–60 45.2 … 23.6 134.3 (12.2) 85.3(10.2) 137.6 (7.9) 91.6 (7.9)
Esposito 2003 34.6 (5) 20–46 100 94.5 (9.3) 34.8 124 (8.5) 85 (4.7) 123 (7.9) 85 (4.9)
Olson 2006 38 (6) 24–44 30 38 (6) 27.6 119 (7.7) 67 (7.7) 119 (11.6) 68 (11.6)
Kinmonth 2008
In Person
40.6 (6) 20–50 62 78.6 (15.6) 27.7 122.6 (12.6) 77.9 (9.0) 122.6 (12.6) 78.2 (9.0)
Kinmonth 2008 
Telephone
40.6 (6) 20–50 62 79.9 (18) 27.8 124.2 (13.0) 79.1 
(10.6)
122.6 (12.6) 78.2 (9.0)
Marquez-Celedonio 
2009
43.2 (7·8) 30–55 . 78.1 (15) 31.2 133.0 (4.4) 87.6 
(2.84)
132.7 (4.2) 85.6 (4.1)
Knoepfli-Lenzin 
2010 Football
37 (4) 20–45 0 82.1 (8.7) 26 134 (7.0) 87 (4.0) 134 (4.0) 86 (3)
Knoepfli-Lenzin 
2010 Running
36 (5) 20–45 0 87.3 (9.4) 26 136 (9.0) 87 (5.0) 134 (4.0) 86 (3)
Edwards 2011 
Aerobic Exercise
45.9 (10.4) 25–65 50 … 30.1 140.6 (9.8) 89.8 
(11.2)
137.6 (11.5) 88.2 (9.2)
Edwards 2011 
Aerobic Exercise 
and Weight Loss
45.9 (10.4) 25–65 50 … 31.2 139.9 (10.5) 85.1 (10) 137.6 (11.5) 88.2 (9.2)
Krustrup 2012 46 (7.3) 31–54 0 97.8 (13.6) 30 151 (10) 92 (7) 153 (8) 96 (6)
Mean values presented with SD. Sex distribution presented as percentage of females included. Missing or unreported values represented as (.). BMI indicates body 
mass index, kg/m2; BP, blood pressure; RCTs, randomized control trials; and TOHP, Trials of Hypertension Prevention.
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Participant Compliance With Intervention and 
Effect on Cardiovascular Fitness and Weight
The majority of studies reported >80% participant compliance 
with intervention at 3 to 6 months, recorded as attendance at 
supervised classes and group meetings, or achievement of 
behavioral targets, such as self-reported minutes of activity. 
However, compliance with behavioral targets dropped to an 
estimated 40% beyond 12 months.
Eight intervention arms deliver exercise in combination 
with weight management, 4 of these interventions report a 
significant reduction in weight loss compared with control at 
3 to 6 months (Figure S3a). Dietary assessment was under-
taken using self-report diaries during periods of 1 to 7 days. 
The majority of studies use diary cards as aids to behavior 
change as opposed to assessing compliance, only 3 stud-
ies report the change in dietary intake. Mean cardiovascular 
fitness was reported from 14 intervention arms, the median 
increase was 12% improvement in peak exercise capacity 
(range, 3%–30%).
Intervention Effect on Blood Pressure
Forest plots for mean differences in systolic and diastolic 
blood pressure after 3 to 6 months of intervention are pre-
sented in Figure 2 (Figure S4a and S4b). Mean difference in 
systolic blood pressure was −4.40 mm Hg (95% CI, −5.78 to 
−3.01) and −4.17 mm Hg (95% CI, −5.42 to −2.93) for dia-
stolic blood pressure when intervention was compared with 
control.
There are no significant differences between intervention 
and control group blood pressures when followed up at, or 
beyond, 12 months (Figure 2; Data Supplement S5a and S5b). 
Mean difference in systolic blood pressure −1.02 mm Hg (95% 
CI, −2.34 to 0.29) and mean difference in diastolic blood pres-
sure was −0.91 mm Hg (95% CI, −1.85 to 0.02).
Subgroup Analysis
I2 statistic identified moderate to considerable heterogeneity 
across the studies (56%–72%) at 3 to 6 months of follow-up. 
Subgroup analysis did not provide a consistent explanation for 
Figure 2. Forest plot demonstrating mean difference in systolic and diastolic blood pressure (mm Hg) after 3 to 6 months (A and B) and 
at, or beyond 12 months (C and D) follow-up. Included studies are all randomized control trial design delivering exercise and physical 
activity lifestyle intervention. Results for individual exercise intervention arms reported when available. Squares represent mean difference 
between intervention and control post intervention with 95% confidence intervals (CIs), size of the square proportional to the weight of the 
study; pooled estimates from meta-analysis are depicted as solid black diamonds.
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heterogeneity between studies for both systolic and diastolic 
blood pressure. I2 statistic reduced to <45% for systolic blood 
pressure when analysis was restricted to hypertensive groups, 
groups with baseline weight >90 kg and self-directed inter-
vention (Table 2).
Supervised aerobic exercise, higher exercise intensity, 
and increased contact time with intervention were associated 
with larger reductions in systolic and diastolic blood pres-
sures (Table 2). Reduction in diastolic blood pressure was sig-
nificantly greater when comparing supervised (−5.43 mm Hg 
[95% CI, −7.58 to −3.28]) with self-directed exercise (−2.64 
mm Hg [95% CI, −3.20 to −2.08]) and when intervention 
targeted higher intensity compared with moderate intensity. 
Blood pressure reductions appeared greater in association 
with >4 kg weight loss, a weight loss threshold identified from 
previous systematic review.32 However, observed differences 
did not reach significance (systolic BP, −5.03 mm Hg [95% 
CI, −6.89 to −3.17] versus −2.61 mm Hg [95% CI, −5.77 
to 0.55] and diastolic BP, −4.77 mm Hg, [95% CI, −6.54 to 
−2.99] versus −2.95 mm Hg [95% CI, −4.76 to −1.13]). There 
were no significant differences in intervention effect when 
groups were separated as hypertensive or prehypertensive at 
baseline (Table 2).
Meta-Regression
The a priori meta-regression model explained 50% of variance 
in intervention effect on systolic blood pressure. Increased 
intensity of exercise and hours of contact with the interven-
tion were significantly associated with reduction in systolic 
blood pressure (Table 3). Baseline mean arterial blood pres-
sure and standard mean difference in weight loss (Figure S3a) 
between exercise and control groups post intervention were 
not significant predictors of mean reduction in systolic blood 
pressure. The a priori model did not provide significant expla-
nation for variance in diastolic blood pressure response.
Discussion
This is the first systematic review to apply age criteria to 
evaluate the RCT evidence base to promote exercise to 
prevent and manage hypertension in younger adults. In the 
short-term (3–6 months), exercise and physical activity 
interventions are beneficial, with between 4 and 5 mm Hg 
Table 2. Subgroup Analysis of Effects of Intervention on Systolic and Diastolic Blood Pressure According to Study Level 
Characteristics
Group Intervention Arms n Systolic BP, mm Hg Diastolic BP, mm Hg
Overall Intervention effect ≤6 months of follow-up 15 2716 −4.40 (−5.78, −3.01)
I 2=56%, Z=6.22 (P<0.00001)
−4·17 (−5·42, −2·93)
I 2=72%, Z=6·57 (P<0·00001)
Intervention effect ≥12 months 8 3023 −1.02 (−2.34, 0.29)
I 2=64%, Z=1.53 (P=0.13)
−0.91 (−1·85, 0·02)
I 2=62%, Z=1.92 (P=0·06)
Baseline weight <90 kg 7 815 −3.0 (−6.04, 0.05)
I 2=72%, Z=1.93 (P=0.05)
−3·88 (−6·13, −1·63)
I 2=73%, Z=3·38 (P=0·0007)
Baseline weight ≥90 kg 5 1806 −4.23(−5.49, −2.98)
I 2=32%, Z=6.6 (P<0.00001)
−3·69 (−5·09, −2·30)
I 2=69%, Z=5·2 (P<0·0001)
Baseline systolic BP <140 mm Hg and Diastolic 
<90 mm Hg
7 2370 −4.41 (−6.06, −2.77)
I 2=69%, Z=5.25 (P<0.00001)
−3·87 (−5·33, −2·41)
I 2=77%, Z=5·20 (P<0·00001)
Baseline systolic BP ≥140 mm Hg and or Diastolic 
≥90 mm Hg
8 346 −4.35 (−7.26, −1.44)
I 2=42%, Z=2.93 (P=0.003)
−4·55 (−6·91, −2·19)
I 2=62%, Z=3·78 (P=0·0002)
Aerobic supervised exercise (follow-up ≤6 months) 11 475 −5.40 (−8.08, −2.72)
I 2=56%, Z=3.95 (P<0.0001)
−5·43 (−7·58, −3·28)
I 2=67%, Z=4·95 (P<0·00001)
Self-directed physical activity (follow-up ≤6 
months)
3 2199 −3.81 (−4.52, −3.09)
I 2=0%, Z=10.39 (P<0.00001)
−2·64 (−3·20, −2·08)
I 2=0%, Z=9·18 (P<0·00001)
Weight loss >4 kg 6 1586 −5.03 (−6.89, −3.17)
I 2=65%, Z=5·31 (P<0.00001)
−4·77 (−6·54, −2·99)
I 2=79%, Z=5·27 (P<0·00001)
Weight loss ≤4 kg 6 1236 −2.61 (−5.77, 0.55)
I 2=61%, Z=2.07 (P=0.11)
−2·95 (−4·76, −1·13)
I 2=53%, Z=3·18 (P=0·001)
Moderate exercise intensity (≤60%) 5 2265 −3.40 (−4.59, −2.21)
I 2=50%, Z=5.60 (P<0.0001)
−2.58 (−3.13, −2.03)
I 2=0%, Z=9.14 (P<0.00001)
Moderate to vigorous intensity (>60%) 10 451 −6.19 (−8.64, −3.73)
I 2=43%, Z=4.93 (P<0.0001)
−5.92 (−8.09, −3.76)
I 2=64%, Z=5.36 (P<0.00001)
Contact time <60 h 9 806 −2.83 (−5.33, −0.34)
I 2=46%, Z=2.23 (P=0.03)
−3.91 (−6.33, −1.49)
I 2=67%, Z=3.16 (P=0.002)
Contact time, ≥60 h 6 1910 −5.61 (−7.55, −3.67)
I 2=69%, Z=5.68 (P<0.00001)
−4.57 (−6.22, −2.92)
I 2=80%, Z=5.42 (P<0.00001)
Results at 3- to 6-month follow-up used unless otherwise stated. Mean differences are pooled estimates from meta-analysis with 95% confidence intervals. I2 values 
reported as measure of heterogeneity. Z scores with associated P values reported as test for overall effect.
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reductions in blood pressure. This is a larger effect than 
reported from a recent review reporting results from older 
adult groups and prehypertension groups.22 This may be 
explained by selection criteria, we excluded normotensive 
cohorts with no cardiovascular risk factors. Alternatively, 
the result may suggest that younger adults may be more 
responsive to exercise as an intervention to lower blood 
pressure. There were also comparable benefits in blood 
pressure reduction for both prehypertension and hyperten-
sion groups, which have not been observed previously in 
older adult groups.22 Early adulthood may be an important 
life stage to target cardiovascular risk reduction. It is iden-
tified as a period where at risk groups present with hyper-
tension.7 In addition, adverse cardiovascular risk profiles 
in early adulthood are predictive of future morbidity.17,33,34 
Transition to early adulthood is identified as a period of 
decline in physical activity,35 with low fitness in early adult-
hood predictive of cardiometabolic dysfunction in middle 
age.36,37 In contrast, maintained or increased cardiovascular 
fitness in younger adults can change cardiovascular risk tra-
jectory.16,38 However, a dominant finding is that we have not 
observed any sustained effects in blood pressure reduction 
from studies reporting outcomes after 12 months. This is 
the first review in the blood pressure literature to explore 
the sustained effects of exercise intervention and the first to 
exclude studies with <3 months follow-up, which may have 
previously contributed to overestimation of effect.22,39 Our 
reported findings are similar to patterns observed in the gen-
eral physical activity literature with a longitudinal decline in 
compliance with maintaining physical activity. The current 
evidence supports the need to build more detailed physical 
activity recommendations for hypertension management in 
younger adult populations.
Current guidelines recommend review of adults below 40 
years of age with elevated blood pressure for exclusion of sec-
ondary causes of hypertension.19 The age inclusion criteria for 
this review were defined to align with this practice. However, 
a major limitation is the paucity of studies recruiting younger 
adults. Hypertension in younger adults is complicated by 
high rates of underdiagnosis and, when identified, suboptimal 
treatment.5,12–14 These deficiencies may reflect broader mis-
conception that younger age is sufficiently protective against 
cardiovascular risk.5,12–14 This pattern is reflected in this review 
with an observed age bias for study recruitment in favor of 
older adults. The majority of excluded trials recruit cohorts 
>50 years of age. In addition, >46% of studies reporting blood 
pressure as a primary outcome excluded participants below 35 
years of age.
Improved risk evaluation and interpretation of the ben-
efits of blood pressure reduction may facilitate discussion 
on how to reform hypertension management for younger 
adults. An example is clinical interpretation of the reported 
4 to 5 mm Hg reduction in blood pressure, if this was sus-
tained in a younger adult cohort with prehypertension, the 
estimated 5-year incidence of hypertension would reduce 
from 1 in 5 to 1 in 10.40 This interpretation may be more 
beneficial than prediction of 10-year risk of cardiovascular 
events, which is difficult in younger adults.41,42 However, 
long-term benefits on cardiovascular end points can be esti-
mated; a sustained 2 mm Hg reduction in blood pressure 
could translate to 7% to 10% reduction in stroke and isch-
emic cardiovascular event.9 The major challenge is how to 
achieve sustained effect. In this review, intervention effect 
dropped to 1 mm Hg by 12 months with no significant dif-
ference compared with control.
To provide a platform to improve future intervention 
design, we present an evaluation of study level character-
istics that predict intervention effect at 3 to 6 months. With 
regard to intervention strategy and delivery, both supervised 
and self-directed exercise achieve reduction in blood pres-
sure, although effect was greater with supervised exercise. 
This may reflect a dose effect; supervised exercise was 
associated with increased exercise participation in the short-
term. This group also achieved higher exercise intensity and 
increased cardiovascular fitness. However, higher volumes 
of planned contact time between participant and interven-
tion, irrespective of intensity, or self-directed exercise were 
also associated with greater reduction in blood pressure at 
3 to 6 months. Explanation for the subgroup analyses may 
relate to distinctions between physiological and behavioral 
influences of intervention. The exposure to higher exercise 
intensity may drive a mechanism for change in blood pres-
sure distinct from low-level activity. Self-directed and lower 
intensity exercise had relatively lower effects on diastolic 
blood pressure, which is consistent with previous observa-
tions that blood pressure responses differ with intervention 
strategy.22,23,32
The finding that contact time, independent of intensity is 
associated with a positive influence on systolic blood pres-
sure may support a beneficial effect of increased frequency 
Table 3. Meta-Regression Model Comparing Effect of Study Level Covariates on Post Intervention Systolic (1) and Diastolic (2) 
Blood Pressure (mm Hg) Compared With Control
Model 1. Systolic Blood Pressure Model 2. Diastolic Blood Pressure
Variable β
1
±SE 95% CI Z (P ) β
1
±SE 95% CI Z (P )
MABP, mm Hg 0.3161±0.1625 −0.0230, 0.6346 1.95 (0.052) −0.0255±0.1966 −0.4108, 0.3599 −0.13 (0.897)
Hours of contact −0.0718±0.0336 −0.1376, −0.0060 −2.14 (0.032) 0.0192±0.0404 −0.0601, 0.0985 0.47 (0.635)
Exercise intensity −0.1458±0.0601 −0.2636, −0.0281 −2.43 (0.015) −0.1275±0.0724 −0.2695, 0.0144 −1.76 (0.078)
Weight loss −0.9610±1.6473 −4.1897, 2.2677 −0.58 (0.560) 2.1510±1.9962 −1.7615, 6.0635 1.08 (0.281)
Model statistics for systolic blood pressure R 2=0.50, Q=16.4, df=4.0, P=0.0025. Model statistics for diastolic blood pressure R 2=0.23, Q=4.95, df=4.0, P=0.293. CI 
indicates confidence intervals; MABP, mean arterial blood pressure at baseline, mm Hg; and Z(p), z-score and P value.
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of low to moderate activity. However, interpretation is limited 
without objective and repeated measures of physical activ-
ity behavior, which was not reported in studies with 3 to 6 
months of outcomes. Alternatively, planned contact, inclusive 
of telephone and remote contact may be a stimulus for sus-
tained behavior. Unfortunately, the pattern across studies is 
that as contact is withdrawn intervention effect declines. This 
is despite several studies implementing recommended behav-
ior strategies, such as promotion of participant self-efficacy, 
activity planning, self-monitoring, and participant feed-
back.25,43 Participant motivation and self-efficacy are of partic-
ular relevance as, despite the low attrition rates, the included 
studies report decline in scheduled attendance and compliance 
with intervention targets from >80% at 3 to 6 months to 40% 
at 18 months. There are currently no strategies that effectively 
address the challenge of promoting sustained long-term physi-
cal activity behavioral change. A promising approach is a 
personalized intervention supported by device-assisted behav-
ioral change and flexible communication strategies to better 
sustain effective intervention.43 The use of wearable activity 
monitors and physical activity tracking applications on mobile 
devices can provide objective measures of behavior, facilitate 
self-monitoring, and allow real-time feedback. However, the 
resource demands of maintaining high contact time and tech-
nology supported behavior change may be a barrier to clini-
cal translation. Economic evaluation of effective interventions 
with reference to delivery cost and process evaluation of 
strategies to sustain participant engagement, motivation, and 
compliance may help to drive innovation and overcome these 
barriers.
Improvement in intervention design and delivery may also 
benefit from more transparency and disclosure of the specific 
methods and content of delivered communication strategies. 
There were often only brief summaries available, which 
described the professional team, if communication training 
was provided to the team, and broad categorical descriptors 
of intervention themes discussed with participants. In the cur-
rent review, several studies focused communication strategies 
around weight loss, promoting exercise as a mechanism for 
weight loss. However, an interesting observation from the 
review which may help to guide the evolution of future stud-
ies is the patterns of intervention effect associated with weight 
loss. Previous review identified that weight loss >4 kg was 
required to achieve significant blood pressure reduction.32 
However, in our review, short-term benefits of exercise on 
blood pressure were seen even in those who did not achieve 
this degree of weight loss. This observation is supported 
by weight loss not being a significant effect modifier in the 
regression model. The positive message is that in the short-
term, exercise is beneficial for blood pressure reduction inde-
pendent of pre- or postintervention weight. Distinguishing 
between the independent benefits of exercise and weight 
loss may facilitate effective communication and participant 
engagement strategies, especially when participants may be 
motivated by different health and well-being goals.
Limitations
Major limitations are the paucity of research studies recruit-
ing younger adult or performing subgroup analysis defined 
by age. Included studies did not present results by age pre-
venting analysis of effect in early adulthood. Evaluation of 
the available literature base would be strengthened by meta-
analysis of individual participant data, but this was outside 
the scope of the review. The results would be strengthened 
by using ambulatory blood pressure, only 3 studies reported 
ambulatory blood pressure in addition to clinic blood pres-
sure. Identification of effective intervention components is 
limited by several study level factors, including lack of objec-
tive measurement and tracking of physical activity behavior, 
limited description of content and delivery of communication 
strategies, and lack of disclosure of effectiveness of intermedi-
ate intervention process outputs such as strategies to maintain 
participant engagement and compliance. In the majority of 
studies, there is also risk of bias in relation to participant allo-
cation concealment and blinding of outcome assessors, with 
methods not discussed or unclear, which may risk overestima-
tion of intervention effectiveness. However, overall the quality 
of included studies were moderate and funnel plots suggest no 
evidence of reporting bias, though caution in interpretation is 
required because of the small number of studies.
Perspectives
This review raises concern that current clinical practice to 
promote lifestyle and exercise intervention risks suboptimal 
management of young adult hypertension. Although it has 
been pragmatic to assume that exercise will improve blood 
pressure in young adults, the available evidence suggests cur-
rent intervention strategies do not maintain long-term ben-
efit. Discussion with young adult patient and public groups 
highlight that lifestyle interventions remain an attractive alter-
native to starting potential lifelong prescriptions for blood 
pressure. However, short-term reduction in blood pressure 
reported in this review involved multiple contacts over time 
and delivery of targeted exercise prescription. These strategies 
generally required supervised exercise interventions, which 
are expensive and currently not widely supported.44 A major 
challenge for the clinical research community is to design 
and evaluate interventions which target sustained increase in 
physical activity behavior, accommodate potential for titration 
of exercise prescription, and deliver improvement in the cost 
per quality adjusted life year. Translation of research findings 
into clinical practice may be improved by study design incor-
porating comparative adaptiveness evaluations and exploring 
interactive effects with prescription medication. Going for-
ward there seems to be a need for strategic overhaul of the 
approaches implemented in the prevention and management 
of young adult blood pressure.
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What Is New?
•	An age defined review of randomized trials, with long-term follow-up, 
designed to assess effectiveness of exercise intervention for blood pres-
sure reduction in younger adults.
What is Relevant?
•	Exercise intervention is beneficial for young adults in the short-term at 
3 to 6 months but has no sustained effect at, or beyond, 12 months. 
Efficacy of intervention at 3 to 6 months was dependent on intensity of 
exercise and contact time with intervention teams.
Summary
Current recommendations for lifestyle and exercise interventions 
risk undertreating younger adults. There is a need for review of 
practice and development of affordable interventions that deliver 
appropriate dose of exercise and sustained behavior change.
Novelty and Significance
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